ATH-063

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug NameATH-063
Drug Alias NameATH-063
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesCrohn DiseaseInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAthos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAthos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesCrohn DiseaseInflammatory Bowel Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A